Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
$1.70−0.17 (-8.85%)
Close on Nov 18, 2026Market cap $30.81MP/E –Yield –
Alterity Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2026 it was -A$22.52M. The highest annual figure on record is -A$5.89M in fiscal 2017.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -A$22.52M | – |
| FY2025 | Jun 30, 2025 | -A$11.45M | – |
| FY2024 | Jun 30, 2024 | -A$12.61M | – |
| FY2023 | Jun 30, 2023 | -A$20.04M | – |
| FY2022 | Jun 30, 2022 | -A$12.43M | – |
| FY2021 | Jun 30, 2021 | -A$17.34M | – |
| FY2020 | Jun 30, 2020 | -A$9.45M | – |
| FY2019 | Jun 30, 2019 | -A$13.96M | – |
| FY2018 | Jun 30, 2018 | -A$6.31M | – |
| FY2017 | Jun 30, 2017 | -A$5.89M | – |
| FY2016 | Jun 30, 2016 | -A$7.42M | – |
See a number that looks wrong?